132 related articles for article (PubMed ID: 32916586)
21. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
Edo N; Morita K; Suzuki H; Takeshita A; Miyakawa M; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
Endocr J; 2016 May; 63(5):469-77. PubMed ID: 26949262
[TBL] [Abstract][Full Text] [Related]
22. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
Espinosa-de-los-Monteros AL; Mercado M; Sosa E; Lizama O; Guinto G; Lopez-Felix B; Garcia O; Hernández I; Ovalle A; Mendoza V
J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
[TBL] [Abstract][Full Text] [Related]
23. Normal Insulin-like Growth Factor 1 During Somatostatin Receptor Ligand Treatment Predicts Surgical Cure in Acromegaly.
Losa M; Garbin E; Pedone E; Mortini P
J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32609842
[TBL] [Abstract][Full Text] [Related]
24. Transsphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patients.
Shirvani M; Motiei-Langroudi R
World Neurosurg; 2014 Jan; 81(1):125-30. PubMed ID: 23313263
[TBL] [Abstract][Full Text] [Related]
25. Pitfalls in early biochemical evaluation after transsphenoidal surgery in patients with acromegaly.
Nishioka H; Fukuhara N; Yamaguchi-Okada M; Takeshita A; Takeuchi Y; Yamada S
Endocr J; 2017 Nov; 64(11):1073-1078. PubMed ID: 28835593
[TBL] [Abstract][Full Text] [Related]
26. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
27. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
Biermasz NR; van Dulken H; Roelfsema F
J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
[TBL] [Abstract][Full Text] [Related]
28. The acromegaly registry of ten different centers in Turkey.
Keskin Ç; Demir Ö; Karcı AÇ; Berker D; Cantürk Z; Yaylali GF; Topsakal Ş; Ersoy R; Bayram F; Ertörer ME; Bozkırlı E; Haydardedeoğlu F; Dilekçi ENA; Ay SA; Cansu GB; Şahin M; Emral R; Çorapçıoğlu D
Growth Horm IGF Res; 2020; 53-54():101322. PubMed ID: 32417639
[TBL] [Abstract][Full Text] [Related]
29. A follow-up study on outcomes of endoscopic transsphenoidal approach for acromegaly.
Aydin S; Ozoner B; Sahin S; Alizada O; Comunoglu N; Oz B; Gazioglu N; Kadioglu P; Tanriover N
Clin Neurol Neurosurg; 2020 Nov; 198():106201. PubMed ID: 32927330
[TBL] [Abstract][Full Text] [Related]
30. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.
Bevan JS; Atkin SL; Atkinson AB; Bouloux PM; Hanna F; Harris PE; James RA; McConnell M; Roberts GA; Scanlon MF; Stewart PM; Teasdale E; Turner HE; Wass JA; Wardlaw JM
J Clin Endocrinol Metab; 2002 Oct; 87(10):4554-63. PubMed ID: 12364434
[TBL] [Abstract][Full Text] [Related]
31. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.
Ahmed S; Elsheikh M; Stratton IM; Page RC; Adams CB; Wass JA
Clin Endocrinol (Oxf); 1999 May; 50(5):561-7. PubMed ID: 10468920
[TBL] [Abstract][Full Text] [Related]
32. Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission.
De P; Rees DA; Davies N; John R; Neal J; Mills RG; Vafidis J; Davies JS; Scanlon MF
J Clin Endocrinol Metab; 2003 Aug; 88(8):3567-72. PubMed ID: 12915637
[TBL] [Abstract][Full Text] [Related]
33. [Acromegaly screening in patients with hyperprolactinemia and pituitary adenoma].
Ukhanova YA; Ilovayskaya IA
Probl Endokrinol (Mosk); 2023 Sep; 70(2):4-10. PubMed ID: 38796756
[TBL] [Abstract][Full Text] [Related]
34. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.
Campbell PG; Kenning E; Andrews DW; Yadla S; Rosen M; Evans JJ
Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130
[TBL] [Abstract][Full Text] [Related]
35. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly.
Bourdelot A; Coste J; Hazebroucq V; Gaillard S; Cazabat L; Bertagna X; Bertherat J
Eur J Endocrinol; 2004 Jun; 150(6):763-71. PubMed ID: 15191345
[TBL] [Abstract][Full Text] [Related]
36. Craniometric changes in patients with acromegaly from a surgical perspective.
Ebner FH; Kürschner V; Dietz K; Bültmann E; Nägele T; Honegger J
Neurosurg Focus; 2010 Oct; 29(4):E3. PubMed ID: 20887128
[TBL] [Abstract][Full Text] [Related]
37. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature.
Almeida JP; Ruiz-Treviño AS; Liang B; Omay SB; Shetty SR; Chen YN; Anand VK; Grover K; Christos P; Schwartz TH
J Neurosurg; 2018 Aug; 129(2):404-416. PubMed ID: 28862548
[TBL] [Abstract][Full Text] [Related]
38. Factors affecting the outcome of surgical treatment of acromegaly.
Er LK; Chang TC; Lin SM; Huang KM; Chang CC
J Formos Med Assoc; 2000 Mar; 99(3):191-8. PubMed ID: 10820950
[TBL] [Abstract][Full Text] [Related]
39. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
Freda PU; Wardlaw SL; Post KD
J Neurosurg; 1998 Sep; 89(3):353-8. PubMed ID: 9724106
[TBL] [Abstract][Full Text] [Related]
40. Treatment results of acromegaly as analyzed by different criteria.
van Lindert E; Hey O; Boecher-Schwarz H; Perneczky A
Acta Neurochir (Wien); 1997; 139(10):905-12; discussion 912-3. PubMed ID: 9401649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
